Damora Therapeutics DMRA
NASDAQ DMRA
$20.50 -0.78 (-3.67%)
As of: Oct 1, 2026 · 12:00 PM EDT

Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026)

Updated

Damora Therapeutics (DMRA) reported Tax Provisions of $300,000 for Q2 2026, compared with $4,000 a year earlier and up 614.3% from the prior quarter.

Analysis

Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Damora Therapeutics' Tax Provisions came in at $386,000; for FY2025, it came in at $50,000, up 22.0% from FY2024.

  • By year, Tax Provisions came in at $41,000 in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Tax Provisions in data going back to Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Damora Therapeutics 1.31 Bn -24.93 Mn - 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 42,000.00
Dec 31, 2025 44,000.00
Jun 30, 2025 4,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 -8,000.00
Sep 30, 2024 7,000.00
Jun 30, 2024 42,000.00
API Access

Damora Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=DMRA&period=max&api_key=YOUR_API_KEY